cbdMD, Inc. (YCBD)
0.488
-0.02
(-4.11%)
USD |
NYAM |
Aug 24, 16:00
cbdMD 1 Year Total Returns (Daily) : -27.16% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -27.16% |
| August 21, 2026 | -20.98% |
| August 20, 2026 | -23.48% |
| August 19, 2026 | -21.88% |
| August 18, 2026 | -30.88% |
| August 17, 2026 | -37.19% |
| August 14, 2026 | -41.64% |
| August 13, 2026 | -37.91% |
| August 12, 2026 | -36.68% |
| August 11, 2026 | -39.79% |
| August 10, 2026 | -35.90% |
| August 07, 2026 | -31.92% |
| August 06, 2026 | -34.04% |
| August 05, 2026 | -32.91% |
| August 04, 2026 | -36.55% |
| August 03, 2026 | -33.78% |
| July 31, 2026 | -43.49% |
| July 30, 2026 | -45.86% |
| July 29, 2026 | -45.67% |
| July 28, 2026 | -45.36% |
| July 27, 2026 | -45.26% |
| July 24, 2026 | -42.15% |
| July 23, 2026 | -39.34% |
| July 22, 2026 | -38.70% |
| July 21, 2026 | -39.06% |
| Date | Value |
|---|---|
| July 20, 2026 | -41.05% |
| July 17, 2026 | -38.46% |
| July 16, 2026 | -32.99% |
| July 15, 2026 | -33.78% |
| July 14, 2026 | -31.49% |
| July 13, 2026 | -29.47% |
| July 10, 2026 | -15.34% |
| July 09, 2026 | -13.83% |
| July 08, 2026 | -13.19% |
| July 07, 2026 | -14.51% |
| July 06, 2026 | -17.21% |
| July 02, 2026 | -25.45% |
| July 01, 2026 | -21.40% |
| June 30, 2026 | -24.53% |
| June 29, 2026 | -22.82% |
| June 26, 2026 | -20.47% |
| June 25, 2026 | -19.20% |
| June 24, 2026 | -24.60% |
| June 23, 2026 | -19.37% |
| June 22, 2026 | -15.84% |
| June 18, 2026 | -14.08% |
| June 17, 2026 | -16.43% |
| June 16, 2026 | -22.14% |
| June 15, 2026 | -22.00% |
| June 12, 2026 | -20.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Tilray Brands, Inc. | -58.96% |
| Organogenesis Holdings, Inc. | -65.85% |
| Guardian Pharmacy Services, Inc. | 46.18% |
| Nektar Therapeutics | 172.6% |
| Elite Pharmaceuticals, Inc. | -47.33% |